# Forrester Research, Inc.: financial statements, quarterly

FORR · Nasdaq · CIK 1023313 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/forr.md) · [Financials](/companies/forr/financials.md) · [Filings](/companies/forr/filings.md) · [Insiders](/companies/forr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/forr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [113](/filings/0000950170-24-123723.md) | [118 d](/filings/0001193125-26-105114.md) | [100](/filings/0000950170-25-068616.md) | [122](/filings/0000950170-25-102448.md) | [103](/filings/0001193125-25-274219.md) | [108 d](/filings/0001193125-26-105114.md) | [89.9](/filings/0001193125-26-213464.md) | [112](/filings/0001193125-26-336932.md) | [94.3](/filings/0001193125-25-274219.md) | [101 d](/filings/0001193125-26-105114.md) | [85.5](/filings/0001193125-26-213464.md) | [100](/filings/0001193125-26-336932.md) |
| Cost of revenue | $m | [44.9](/filings/0000950170-24-123723.md) | [52.8 d](/filings/0000950170-24-028381.md) | [45.1](/filings/0000950170-24-052499.md) | [52.0](/filings/0000950170-24-090357.md) | [40.5](/filings/0000950170-24-123723.md) | [48.2 d](/filings/0001193125-26-105114.md) | [39.6](/filings/0001193125-26-213464.md) | [49.7](/filings/0001193125-26-336932.md) | [37.7](/filings/0001193125-25-274219.md) | [43.8 d](/filings/0001193125-26-105114.md) | [38.6](/filings/0001193125-26-213464.md) | [43.7](/filings/0001193125-26-336932.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [60.5](/filings/0000950170-24-123723.md) | [65.9 d](/filings/0001193125-26-105114.md) | [56.6](/filings/0000950170-25-068616.md) | [57.4](/filings/0000950170-25-102448.md) | [56.9](/filings/0001193125-25-274219.md) | [63.1 d](/filings/0001193125-26-105114.md) | [53.5](/filings/0001193125-26-213464.md) | [55.1](/filings/0001193125-26-336932.md) | [51.3](/filings/0001193125-25-274219.md) | [58.5 d](/filings/0001193125-26-105114.md) | [52.0](/filings/0001193125-26-213464.md) | [50.4](/filings/0001193125-26-336932.md) |
| Operating income | $m | [5.1](/filings/0000950170-24-123723.md) | [(1.4) d](/filings/0001193125-26-105114.md) | [(9.3)](/filings/0000950170-25-068616.md) | [11.3](/filings/0000950170-25-102448.md) | [(0.7)](/filings/0001193125-25-274219.md) | [(0.6) d](/filings/0001193125-26-105114.md) | [(87.6)](/filings/0001193125-26-213464.md) | [7.0](/filings/0001193125-26-336932.md) | [4.5](/filings/0001193125-25-274219.md) | [(37.0) d](/filings/0001193125-26-105114.md) | [(18.6)](/filings/0001193125-26-213464.md) | [3.4](/filings/0001193125-26-336932.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.4](/filings/0000950170-24-123723.md) | [(0.6) d](/filings/0001193125-26-105114.md) | [(2.1)](/filings/0000950170-25-068616.md) | [5.3](/filings/0000950170-25-102448.md) | [4.7](/filings/0001193125-25-274219.md) | [0.5 d](/filings/0001193125-26-105114.md) | [(1.0)](/filings/0001193125-26-213464.md) | [3.2](/filings/0001193125-26-336932.md) | [0.4](/filings/0001193125-25-274219.md) | [(2.7) d](/filings/0001193125-26-105114.md) | [3.1](/filings/0001193125-26-213464.md) | [(12.3)](/filings/0001193125-26-336932.md) |
| Net income | $m | [2.5](/filings/0000950170-24-123723.md) | [(0.7) d](/filings/0001193125-26-105114.md) | [(6.7)](/filings/0000950170-25-068616.md) | [6.3](/filings/0000950170-25-102448.md) | [(5.8)](/filings/0001193125-25-274219.md) | [0.4 d](/filings/0001193125-26-105114.md) | [(87.3)](/filings/0001193125-26-213464.md) | [3.9](/filings/0001193125-26-336932.md) | [(2.1)](/filings/0001193125-25-274219.md) | [(33.9) d](/filings/0001193125-26-105114.md) | [(21.8)](/filings/0001193125-26-213464.md) | [15.3](/filings/0001193125-26-336932.md) |
| Diluted EPS | $ per share | [0.13](/filings/0000950170-24-123723.md) | not reported | [(0.35)](/filings/0000950170-25-068616.md) | [0.33](/filings/0000950170-25-102448.md) | [(0.30)](/filings/0001193125-25-274219.md) | not reported | [(4.62)](/filings/0001193125-26-213464.md) | [0.20](/filings/0001193125-26-336932.md) | [(0.11)](/filings/0001193125-25-274219.md) | not reported | [(1.14)](/filings/0001193125-26-213464.md) | [0.78](/filings/0001193125-26-336932.md) |
| Basic EPS | $ per share | [0.13](/filings/0000950170-24-123723.md) | not reported | [(0.35)](/filings/0000950170-25-068616.md) | [0.33](/filings/0000950170-25-102448.md) | [(0.30)](/filings/0001193125-25-274219.md) | not reported | [(4.62)](/filings/0001193125-26-213464.md) | [0.21](/filings/0001193125-26-336932.md) | [(0.11)](/filings/0001193125-25-274219.md) | not reported | [(1.14)](/filings/0001193125-26-213464.md) | [0.79](/filings/0001193125-26-336932.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [102](/filings/0000950170-24-123723.md) | [72.9](/filings/0000950170-25-035158.md) | [61.4](/filings/0000950170-25-068616.md) | [58.9](/filings/0000950170-25-102448.md) | [62.8](/filings/0001193125-25-274219.md) | [56.1](/filings/0001193125-26-105114.md) | [75.6](/filings/0001193125-26-213464.md) | [67.8](/filings/0001193125-26-336932.md) | [65.1](/filings/0001193125-25-274219.md) | [63.3](/filings/0001193125-26-336932.md) | [73.9](/filings/0001193125-26-213464.md) | [59.5](/filings/0001193125-26-336932.md) |
| Current assets | $m | [185](/filings/0000950170-23-060715.md) | [216](/filings/0000950170-25-035158.md) | [219](/filings/0000950170-24-052499.md) | [193](/filings/0000950170-24-090357.md) | [194](/filings/0000950170-24-123723.md) | [201](/filings/0001193125-26-105114.md) | [218](/filings/0000950170-25-068616.md) | [214](/filings/0000950170-25-102448.md) | [194](/filings/0001193125-25-274219.md) | [213](/filings/0001193125-26-336932.md) | [218](/filings/0001193125-26-213464.md) | [222](/filings/0001193125-26-336932.md) |
| Total assets | $m | [536](/filings/0000950170-23-060715.md) | [564](/filings/0000950170-25-035158.md) | [556](/filings/0000950170-24-052499.md) | [524](/filings/0000950170-24-090357.md) | [505](/filings/0000950170-24-123723.md) | [504](/filings/0001193125-26-105114.md) | [440](/filings/0000950170-25-068616.md) | [436](/filings/0000950170-25-102448.md) | [414](/filings/0001193125-25-274219.md) | [404](/filings/0001193125-26-336932.md) | [409](/filings/0001193125-26-213464.md) | [417](/filings/0001193125-26-336932.md) |
| Current liabilities | $m | [216](/filings/0000950170-23-060715.md) | [240](/filings/0000950170-25-035158.md) | [241](/filings/0000950170-24-052499.md) | [212](/filings/0000950170-24-090357.md) | [198](/filings/0000950170-24-123723.md) | [204](/filings/0001193125-26-105114.md) | [224](/filings/0000950170-25-068616.md) | [197](/filings/0000950170-25-102448.md) | [182](/filings/0001193125-25-274219.md) | [240](/filings/0001193125-26-336932.md) | [238](/filings/0001193125-26-213464.md) | [209](/filings/0001193125-26-336932.md) |
| Total liabilities | $m | [303](/filings/0000950170-23-060715.md) | [324](/filings/0000950170-25-035158.md) | [325](/filings/0000950170-24-052499.md) | [287](/filings/0000950170-24-090357.md) | [271](/filings/0000950170-24-123723.md) | [274](/filings/0001193125-26-105114.md) | [292](/filings/0000950170-25-068616.md) | [276](/filings/0000950170-25-102448.md) | [257](/filings/0001193125-25-274219.md) | [278](/filings/0001193125-26-336932.md) | [303](/filings/0001193125-26-213464.md) | [295](/filings/0001193125-26-336932.md) |
| Long-term debt | $m | [35.0](/filings/0000950170-23-060715.md) | [35.0](/filings/0000950170-25-035158.md) | [35.0](/filings/0000950170-24-052499.md) | [35.0](/filings/0000950170-24-090357.md) | [35.0](/filings/0000950170-24-123723.md) | [35.0](/filings/0001193125-26-105114.md) | [35.0](/filings/0000950170-25-068616.md) | [35.0](/filings/0000950170-25-102448.md) | [35.0](/filings/0001193125-25-274219.md) | [0.0](/filings/0001193125-26-336932.md) | [35.0](/filings/0001193125-26-213464.md) | [35.0](/filings/0001193125-26-336932.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-105114.md) | not reported | not reported | not reported | [35.0](/filings/0001193125-26-336932.md) | [0.0](/filings/0001193125-26-213464.md) | [0.0](/filings/0001193125-26-336932.md) |
| Shareholders' equity | $m | [233](/filings/0000950170-24-123723.md) | [240](/filings/0001193125-26-105114.md) | [231](/filings/0000950170-25-102448.md) | [237](/filings/0001193125-25-274219.md) | [234](/filings/0001193125-25-274219.md) | [230](/filings/0001193125-26-336932.md) | [147](/filings/0001193125-26-336932.md) | [160](/filings/0001193125-26-336932.md) | [158](/filings/0001193125-25-274219.md) | [127](/filings/0001193125-26-336932.md) | [106](/filings/0001193125-26-336932.md) | [122](/filings/0001193125-26-336932.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.0) d](/filings/0000950170-24-123723.md) | [11.9 d](/filings/0001193125-26-105114.md) | [0.6](/filings/0000950170-25-068616.md) | [(2.9) d](/filings/0000950170-25-102448.md) | [0.3 d](/filings/0001193125-25-274219.md) | [(1.8) d](/filings/0001193125-26-105114.md) | [26.7](/filings/0001193125-26-213464.md) | [(3.6) d](/filings/0001193125-26-336932.md) | [1.2 d](/filings/0001193125-25-274219.md) | [(3.2) d](/filings/0001193125-26-105114.md) | [25.6](/filings/0001193125-26-213464.md) | [(0.6) d](/filings/0001193125-26-336932.md) |
| Capital expenditure | $m | [1.2 d](/filings/0000950170-24-123723.md) | [1.6 d](/filings/0001193125-26-105114.md) | [1.4](/filings/0000950170-25-068616.md) | [0.8 d](/filings/0000950170-25-102448.md) | [0.5 d](/filings/0001193125-25-274219.md) | [0.7 d](/filings/0001193125-26-105114.md) | [0.6](/filings/0001193125-26-213464.md) | [0.6 d](/filings/0001193125-26-336932.md) | [0.7 d](/filings/0001193125-25-274219.md) | [1.1 d](/filings/0001193125-26-105114.md) | [6.2](/filings/0001193125-26-213464.md) | [12.0 d](/filings/0001193125-26-336932.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [3.3 d](/filings/0000950170-24-123723.md) | [0.0 d](/filings/0001193125-26-105114.md) | [4.1](/filings/0000950170-25-068616.md) | [3.9 d](/filings/0000950170-25-102448.md) | [5.0 d](/filings/0001193125-25-274219.md) | [2.9 d](/filings/0001193125-26-105114.md) | [0.0](/filings/0000950170-25-068616.md) | [0.0 d](/filings/0001193125-26-336932.md) | [2.4 d](/filings/0001193125-25-274219.md) | [0.1 d](/filings/0001193125-26-105114.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.1](/filings/0000950170-23-060715.md) | [19.1](/filings/0000950170-24-052499.md) | [19.3](/filings/0000950170-24-090357.md) | [19.3](/filings/0000950170-24-123723.md) | [19.3](/filings/0000950170-25-068616.md) | [19.1](/filings/0000950170-25-102448.md) | [19.1](/filings/0001193125-25-274219.md) | [18.9](/filings/0001193125-26-213464.md) | [19.2](/filings/0001193125-26-336932.md) | [19.1](/filings/0001193125-25-274219.md) | [19.1](/filings/0001193125-26-213464.md) | [19.5](/filings/0001193125-26-336932.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,039,000 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-336932.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.